These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 10556948

  • 1. Mechanisms underlying the impairment of endothelium-dependent relaxation in the pulmonary artery of monocrotaline-induced pulmonary hypertensive rats.
    Nakazawa H, Hori M, Ozaki H, Karaki H.
    Br J Pharmacol; 1999 Nov; 128(5):1098-104. PubMed ID: 10556948
    [Abstract] [Full Text] [Related]

  • 2. Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats.
    Ozturk EI, Uma S.
    J Cardiovasc Pharmacol; 2010 Nov; 56(5):498-505. PubMed ID: 20729759
    [Abstract] [Full Text] [Related]

  • 3. [TRPC6 mediates the enhancements of pulmonary arterial tone and intracellular Ca2+ concentration of pulmonary arterial smooth muscle cells in pulmonary hypertension rats].
    Zhang MF, Liu XR, Yang N, Lin MJ.
    Sheng Li Xue Bao; 2010 Feb 25; 62(1):55-62. PubMed ID: 20179889
    [Abstract] [Full Text] [Related]

  • 4. Activity of endothelium-derived hyperpolarizing factor is augmented in monocrotaline-induced pulmonary hypertension of rat lungs.
    Morio Y, Homma N, Takahashi H, Yamamoto A, Nagaoka T, Sato K, Muramatsu M, Fukuchi Y.
    J Vasc Res; 2007 Feb 25; 44(4):325-35. PubMed ID: 17438361
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
    Mathew R, Zeballos GA, Tun H, Gewitz MH.
    Cardiovasc Res; 1995 Nov 25; 30(5):739-46. PubMed ID: 8595621
    [Abstract] [Full Text] [Related]

  • 7. Endothelial nitric oxide synthase-enhancing G-protein coupled receptor antagonist inhibits pulmonary artery hypertension by endothelin-1-dependent and endothelin-1-independent pathways in a monocrotaline model.
    Liu CP, Dai ZK, Huang CH, Yeh JL, Wu BN, Wu JR, Chen IJ.
    Kaohsiung J Med Sci; 2014 Jun 25; 30(6):267-78. PubMed ID: 24835346
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of monocrotaline-induced pulmonary arterial hypertension in rats by rosuvastatin.
    Li XL, Guan RJ, Li JJ.
    J Cardiovasc Pharmacol; 2012 Aug 25; 60(2):219-26. PubMed ID: 22592772
    [Abstract] [Full Text] [Related]

  • 9. Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats.
    Kodama K, Adachi H.
    J Pharmacol Exp Ther; 1999 Aug 25; 290(2):748-52. PubMed ID: 10411587
    [Abstract] [Full Text] [Related]

  • 10. [Effects of rosuvastatin on monocrotaline-induced pulmonary artery hypertension in rats].
    Li XL, Guan RJ, Xu QH, Wu ZY.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Mar 25; 39(3):247-53. PubMed ID: 21609531
    [Abstract] [Full Text] [Related]

  • 11. L-arginine restores endothelial nitric oxide synthase-coupled activity and attenuates monocrotaline-induced pulmonary artery hypertension in rats.
    Ou ZJ, Wei W, Huang DD, Luo W, Luo D, Wang ZP, Zhang X, Ou JS.
    Am J Physiol Endocrinol Metab; 2010 Jun 25; 298(6):E1131-9. PubMed ID: 20215577
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme 2 activation ameliorates pulmonary endothelial dysfunction in rats with pulmonary arterial hypertension through mediating phosphorylation of endothelial nitric oxide synthase.
    Li G, Zhang H, Zhao L, Zhang Y, Yan D, Liu Y.
    J Am Soc Hypertens; 2017 Dec 25; 11(12):842-852. PubMed ID: 29146157
    [Abstract] [Full Text] [Related]

  • 13. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension.
    Murata T, Sato K, Hori M, Ozaki H, Karaki H.
    J Biol Chem; 2002 Nov 15; 277(46):44085-92. PubMed ID: 12185080
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N, Morio Y, Takahashi H, Yamamoto A, Suzuki T, Sato K, Muramatsu M, Fukuchi Y.
    Respiration; 2006 Nov 15; 73(1):105-12. PubMed ID: 16432296
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Essential role of nitric oxide in sepsis-induced impairment of endothelium-derived hyperpolarizing factor-mediated relaxation in rat pulmonary artery.
    Subramani J, Leo MD, Kathirvel K, Arunadevi R, Singh TU, Prakash VR, Mishra SK.
    Eur J Pharmacol; 2010 Mar 25; 630(1-3):84-91. PubMed ID: 20035746
    [Abstract] [Full Text] [Related]

  • 19. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease.
    Zhao YD, Courtman DW, Deng Y, Kugathasan L, Zhang Q, Stewart DJ.
    Circ Res; 2005 Mar 04; 96(4):442-50. PubMed ID: 15692087
    [Abstract] [Full Text] [Related]

  • 20. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
    Guerard P, Rakotoniaina Z, Goirand F, Rochette L, Dumas M, Lirussi F, Bardou M.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep 04; 373(6):401-14. PubMed ID: 16896805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.